BusinessRitter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 19, 2018, 10:35 AM UTC
BusinessRitter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose IntoleranceBy Nasdaq OMXOct 3, 2017, 4:00 PM UTC
